Company News

Share this article:
Cell Biosciences, a private life sciences company focused on protein and biomarketer research, will acquire Alpha Innotech Corp, a high-sensitivity digital imaging systems manufacturer, for $17.9 million. The acquisition will expand Cell Biosciences' protein analysis business to include a global infrastructure and a broad protein analysis product portfolio, according to a statement. Cell Biosciences' lead product candidate is CB1000, a nanfluidic immunoassay platform designed for detecting proteins in small biological samples, such as small tumor biopsies and stem cells.

Neoprobe Corporation, a developer of oncology surgical and diagnostic products, and Laureate Pharma, a biopharma development and protein production company, announced a manufacturing alliance, or a biopharmaceutical development and manufacturing agreement. Terms of the agreement were not disclosed.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.